Our experts in new drug development provide solutions to effectively conduct clinical development in Japan
We propose flexible partnering strategy, utilizing our clinical development unit
Eisai and TSD Japan Enter into a License and Joint Development Agreement of Denileukin Diftitox in Japan.
Back Number